• 1
    Kenyon IE. Unplanned pregnancy in an epileptic. BMJ 1972;1: 6867.
  • 2
    Coulan CB, Annegers JF. Do anticonvulsants reduce the efficacy of oral contraceptives? Epilepsia 1979;20: 51926.
  • 3
    Wilbur K, Ensom MHH. Pharmacokinetic drug interactions between oral contraceptives and second-generation anticonvulsants. Clin Pharmacokinet 2000;38: 35565.
  • 4
    Crawford P. Interactions between antiepileptic drugs and hormonal contraception. CNS Drugs 2002;16: 26572.
  • 5
    Crawford PM, Chadwick DJ, Martin C, et al. The interaction of phenytoin and carbamazepine with combined oral contraceptives steroids. Br J Clin Pharmacol 1990;30: 8926.
  • 6
    Crawford P, Chadwick D, Cleland P, et al. The lack of effect of sodium valproate on the pharmacokinetics of oral contraceptives. Contraception 1986;33: 239.
  • 7
    Bialer M, Johannessen SI, Kupferberg HJ, et al. Progress report on new antiepileptic drugs: a summary of the Sixth Eilat Conference (EILAT VI). Epilepsy Res 2002;51: 3171.
  • 8
    Golzieher JW. Pharmacokinetics and metabolism of ethinyl estrogens. In: GolzieherJW, FotherbyK, eds. Pharmacology of the contraceptive steroids. New York: Raven Press, 1994: 12751.
  • 9
    Emery MG. Estrogens and progestins. In: LevyRH, ThummelKE, TragerWF, et al., eds. Metabolic drug interactions. Philadelphia: Lippincott Williams & Wilkins, 2000: 51128.
  • 10
    Back D, Breckenridge A, Maclver M, et al. The gut wall metabolism of ethinylestradiol and its contribution to the presystemic metabolism of ethinylestradiol in humans. Br J Clin Pharmacol 1982;13: 32530.
  • 11
    Rosenfeld WE, Doose DR, Walker SA, et al. Effect of topiramate on the pharmacokinetics of an oral contraceptive containing norethindrone and ethinyl estradiol in patients with epilepsy. Epilepsia 1997;38: 31723.
  • 12
    Doose D, Jacobs D, Squires L, et al. Oral contraceptive-AED interactions: no effect of topiramate as monotherapy at clinically effective dosages of 200 mg or less. Epilepsia 2002;43(suppl 7):205.
  • 13
    Doose D, Jacobs D, Squires L, et al. Clinically effective topiramate (TPM) dosages (50–200 mg/day): no pharmacokinetic interaction with oral contraceptives (OCs). Epilepsia 2002;43(suppl 8):146.
  • 14
    Ragueneau-Majlessi I, Levy RH, Janik F. Levetiracetam does not alter the pharmacokinetics of an oral contraceptive in healthy women. Epilepsia 2002;43: 697702.
  • 15
    Chang I, McAuley JW. Pharmacotherapeutic issues for women of childbearing age with epilepsy. Ann Pharmacother 1998;32: 794801.
  • 16
    Klosterskov Jensen P, Saano V, Haring P, et al. Possible interaction between oxcarbazepine and an oral contraceptive. Epilepsia 1992;33: 114952.
  • 17
    Fattore C, Cipolla C, Gatti G, et al. Induction of ethinylestradiol and levonorgestrol metabolism by oxcarbazepine in healthy women. Epilepsia 1999;40: 7837.
  • 18
    Gatti G, Bonomi I, Jannuzi G, et al. The new antiepileptic drugs: pharmacological and clinical aspects. Curr Pharm Design 2000;6: 83960.
  • 19
    Saano V, Glue P, Banfield CR, et al. Effect of felbamate on the pharmacokinetics of a low-dose combination oral contraceptive. Clin Pharmacol Ther 1995;58: 52331.
  • 20
    Eldon MA, Underwood BA, Randinitis EJ, et al. Gabapentin does not interact with a contraceptive regimen of norethindrone acetate and ethinyl estradiol. Neurology 1998;50: 11468.
  • 21
    Holdich T, Whiteman P, Orme M, et al. Effect of lamotrigine on the pharmacology of the combined oral contraceptive pill. Epilepsia 1991;32(suppl 1):96.
  • 22
    Mengel HB, Houston A, Back DJ. An evaluation of the interaction between tiagabine and oral contraceptive in female volunteers. J Pharm Med 1994;4: 14150.
  • 23
    Bartoli A, Gatti G, Cipolla G, et al. A double blind, placebo controlled study on the effect of vigabatrin on in vivo parameters of hepatic microsomal enzyme induction and on the kinetics of steroid oral contraceptives in healthy female volunteers. Epilepsia 1997;38: 7027.